Discover the innovative work being done by California Life Science member companies.
Submit Your Content
CLS encourages our members to share their recent news, initiatives, milestones and thought leadership to foster an ecosystem of innovation and collaboration.
CLS members can submit articles, press releases, whitepapers, and/or blogs to be featured on the ‘Member Voice’ section of our website, which will also be amplified on CLS social media channels and could be spotlighted in our bi-weekly newsletter, CLS Bulletin*.
Learn more about all of the ways CLS elevates the voice of our members. Not yet a member? Join CLS today to start taking advantage of this exclusive member benefit.
To be eligible, organizations must meet the following criteria:
- Be an active CLS member.
- Content should complement CLS’s mission of empowering our life sciences community to deliver innovative solutions for healthier lives.
- Highlight your current organizational initiatives, press releases, patient stories, recent news articles, challenges and opportunities for our industry, areas of focus, major milestones, success stories, etc.
- Include a high-resolution .png or .jpg logo
- No more than two organizational submissions per month
*Spotlight submissions will be selected at the discretion of CLS and featured in our bi-weekly newsletter.
Member News
Research Matters: Ending breast cancer, together
September 3rd, 2024 – Breast cancer is the leading cause of cancer-related deaths among women and is also the most common cancer worldwide. Together we can raise awareness and support breast cancer researchers around the world. Join us again this October for our ‘Research Matters’ campaign. For the month of October, Cytiva will donate $1 to the Breast Cancer Research Foundation (BCRF) for select consumables ordered. Read more here!
MaxCyte Announces Collaboration with ScaleReady to Participate in the G-Rex Grant Program
September 6th, 2024 – MaxCyte, Inc. has partnered with ScaleReady to participate in the $20M G-Rex® Grant Program. This initiative aims to accelerate cell and gene therapy development by providing commercial, manufacturing, and academic institutions with essential resources to rapidly implement G-Rex-centric manufacturing platforms. Read more here!
Sapio Sciences Advances The World’s First AI-Powered Lab Assistant
August 30th, 2024 – Sapio Sciences, the science-awareTM lab informatics platform, today announced significant enhancements to Sapio ELaiN, the pioneering AI-powered lab assistant that helps scientists streamline processes and work more efficiently. Read more here!
What’s Current in Life Science Real Estate
August 28, 2024 – Recent lease transactions: Generous rent concessions and shorter lease terms remain market trends. Read more here!
ARIZ Precision Medicine Announces Grant of Key US Patent Covering Lead Cancer Drug
August 27, 2024 – ARIZ Precision Medicine, Inc., a preclinical stage biopharmaceutical company developing precision ligand targeted siRNA cancer therapies, today announced the issuance of a broad patent for a highly specific drug candidate (ARIZ-047) that has been shown to be highly effective in killing lung cancer cells in both cell culture and animal model experiments. Read more here!
LifeSpace Labs Launches Newest Training Program
August 27, 2024 – LifeSpace Labs is thrilled to offer our first Biotechnology Training Program in Next Generation Sequencing starting this Fall at LifeSpace Labs in Vacaville, CA! This immersive and free-of-cost six-week course will provide hands-on experience with Next Generation Sequencing (NGS) using the Illumina platform. Read more here!
EPAM Joins Sapio Sciences Partner Program
August 27, 2024 – Sapio Sciences, the science-awareTM lab informatics platform, today announced that EPAM, a leading global provider of digital platform engineering and development services, has joined the Sapio Sciences Partner Program as a services partner, delivering consulting and implementation services to the complex health and medical ecosystem. Read more here!
Introducing The NEW Research Accelerator for Follicular Lymphoma (RAFL) Program, which is now Accepting Letters of Intent Through
August 20, 2024 – The Research Accelerator for Follicular Lymphoma (RAFL) is a strategic partnership between the Institute for Follicular Lymphoma Innovation (IFLI) and The Leukemia & Lymphoma Society (LLS), committing at least $20 million over seven years to foster innovative research in Follicular Lymphoma (FL). RAFL aims to tackle challenging issues in FL by funding ambitious research proposals globally, with two funding cycles planned: RAFL-I (opening 2024) and RAFL-II (opening 2026). Read more here!
Sapio Sciences and CREO Announce Strategic Partnership
August 14, 2024 – Sapio Sciences, the science-awareTM lab informatics platform, today announced a new strategic partnership with CREO, the preferred consultancy to the world’s most promising companies that seek to improve human health, to deliver comprehensive, end-to-end laboratory information management solutions. Read more here!
AnimalBiome Releases 2024 State of the Gut Report: The Importance of Studying Our Pets’ Poop for Their Health and Longevity
August 14, 2024 – AnimalBiome, a leader in pet microbiome science, announces the release of the 2024 State of the Gut report as part of its mission to improve the health of companion animals. Based on a survey of 2,224 pet parents and AnimalBiome’s database of over 50,000 stool samples, the report provides crucial insights and best practices for supporting companion animal gut health. Read more here!
Sapio Sciences and Zifo Announce Strategic Partnership
August 9, 2024 – Sapio Sciences, the science-awareTM lab informatics platform, and Zifo, the leading scientific informatics services company today announced a strategic partnership to bring best-in-class laboratory information management solutions to customers across the biotech, clinical diagnostics, and pharmaceutical industries. Read more here!
Global Life Sciences/Healthcare Entrepreneurship Course – Virtual Master Class Direct from Silicon Valley
August 9, 2024 – Learn how to start a life sciences/healthcare company with experts from Silicon Valley in UCSF’s professional class. The 6th cohort of UCSF’s acclaimed life science/healthcare entrepreneurship course starts in Fall 2024. This virtual course is live and online, takes place over a 10 week period and requires only 2-4 hours per week. All lectures are recorded for reference. Read more here!
Member Events
Aton – Series of Strategies and Best Practices for Mastering the Development, Quality Control, and Formulation of Advanced Biologics
September 16 @ 10:00 am - September 20 @ 11:00 amSapio Sessions San Diego
September 17 @ 10:45 am - 2:30 pmSapio Sessions San Francisco
September 19 @ 10:45 am - 2:30 pm
Welcome to California Life Sciences Newest Members
Join The Conversation
